NCT05834829

Brief Summary

Studying the effects of Low Intensity Focused Ultrasound (LIFU) to the dorsal posterior insula (dPI) and dorsal anterior cingulate cortex (dACC) on autonomic control using a test to probe the autonomic system. A cold pressor task will be performed pre and post LIFU application. Physiologic recordings will be recorded throughout.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
8mo left

Started Feb 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress77%
Feb 2024Dec 2026

First Submitted

Initial submission to the registry

January 12, 2023

Completed
4 months until next milestone

First Posted

Study publicly available on registry

April 28, 2023

Completed
10 months until next milestone

Study Start

First participant enrolled

February 22, 2024

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2026

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2026

Expected
Last Updated

June 6, 2025

Status Verified

June 1, 2025

Enrollment Period

2.2 years

First QC Date

January 12, 2023

Last Update Submit

June 3, 2025

Conditions

Outcome Measures

Primary Outcomes (5)

  • Sympathetic tone response - Heart Rate Variability (HRV)

    Changes in HRV

    through study completion, an average of 1 month

  • Sympathetic tone response - Heart Rate (HR)

    Changes in HR

    through study completion, an average of 1 month

  • Sympathetic tone response - Blood Pressure (BP)

    Changes in BP (systolic and diastolic pressure)

    through study completion, an average of 1 month

  • Sympathetic tone response - Electrodermal Response (EDR)

    Changes in EDR

    through study completion, an average of 1 month

  • Sympathetic tone response - Electroencephalography (EEG)

    Changes in low and high frequency power

    through study completion, an average of 1 month

Study Arms (3)

dPI

EXPERIMENTAL

LIFU to the dPI

Device: Low-intensity focused ultrasound neuromodulation

ACC

EXPERIMENTAL

LIFU to the ACC

Device: Low-intensity focused ultrasound neuromodulation

Sham

SHAM COMPARATOR

Sham LIFU application

Device: Sham Low-intensity focused ultrasound

Interventions

ultrasound transducer applying low intensity waveforms to targeted brain regions for neuromodulation.

ACCdPI

sham application of ultrasound using blocking of the ultrasound waves of the transducer.

Sham

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • Claustrophobia (scanning environment may be uncomfortable).
  • Contraindications to MRI: including pacemaker, aneurysm clips, neurostimulators, cochlear implants, metal in eyes, steel worker, or other implants.
  • Contraindications to CT: pregnancy
  • Active medical disorder or treatment with potential central nervous system (CNS) effects (e.g. Alzheimer's) -
  • History of neurologic disorder. (e.g. Parkinson's, Epilepsy, or Essential Tremor)
  • History of head injury resulting in loss of consciousness for \>10 minutes.
  • History of alcohol or drug dependence (through self-report).
  • History of cardiac disease
  • A current or prior use of any cardiac medication (e.g. beta blockers or other anti-arrhythmics)
  • A history of diabetes mellitus or use of diabetic medications (e.g. metformin).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fralin Biomedical Research Institute at VTC

Roanoke, Virginia, 24016, United States

Location

MeSH Terms

Conditions

Primary Dysautonomias

Condition Hierarchy (Ancestors)

Autonomic Nervous System DiseasesNervous System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Sham application during a single randomized session (1 of 3 sessions).
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: three arm model, participants receive each intervention/sham (dPI, ACC, or Sham) one per study visit in a randomized order.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

January 12, 2023

First Posted

April 28, 2023

Study Start

February 22, 2024

Primary Completion

April 30, 2026

Study Completion (Estimated)

December 30, 2026

Last Updated

June 6, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations